---
figid: PMC7884707__41392_2020_430_Fig4_HTML
figlink: pmc/articles/PMC7884707/figure/Fig4/
number: F4
caption: Wnt/β-Catenin signaling pathway-mediated therapy resistance in CSCs. In the
  absence of Wnt signaling, β-catenin is bound to the Axin complex, which contains
  APC and GSK3β and is, phosphorylated, leading to ubiquitination and proteasomal
  degradation through the β-Trcp pathway. In the presence of Wnt signaling, the binding
  of LRP5/6 and FZD inhibits the activity of the Axin complex and the phosphorylation
  of β-catenin, allowing β-catenin to enter the nucleus, and then bind to TEF/TCF
  to form a complex, which then recruits cofactors to initiate downstream gene expression.
  Several proteins (CDH1, SMOC2, SOX8, PAF, PTK2, CD44 and ID1) along with miR-708-5p
  regulate Sorafenib resistance, Differential therapy resistance, Cisplatin resistance,
  Paclitaxel resistance and Castration resistance
pmcid: PMC7884707
papertitle: 'Targeting cancer stem cells for reversing therapy resistance: mechanism,
  signaling, and prospective agents.'
reftext: He-Ming Zhou, et al. Signal Transduct Target Ther. 2021;6:62.
pmc_ranked_result_index: '13213'
pathway_score: 0.9114478
filename: 41392_2020_430_Fig4_HTML.jpg
figtitle: Wnt/Beta-Catenin signaling pathway-mediated therapy resistance in CSCs
year: '2021'
organisms:
- Mus musculus
- Drosophila melanogaster
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7884707__41392_2020_430_Fig4_HTML.html
  '@type': Dataset
  description: Wnt/β-Catenin signaling pathway-mediated therapy resistance in CSCs.
    In the absence of Wnt signaling, β-catenin is bound to the Axin complex, which
    contains APC and GSK3β and is, phosphorylated, leading to ubiquitination and proteasomal
    degradation through the β-Trcp pathway. In the presence of Wnt signaling, the
    binding of LRP5/6 and FZD inhibits the activity of the Axin complex and the phosphorylation
    of β-catenin, allowing β-catenin to enter the nucleus, and then bind to TEF/TCF
    to form a complex, which then recruits cofactors to initiate downstream gene expression.
    Several proteins (CDH1, SMOC2, SOX8, PAF, PTK2, CD44 and ID1) along with miR-708-5p
    regulate Sorafenib resistance, Differential therapy resistance, Cisplatin resistance,
    Paclitaxel resistance and Castration resistance
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - FZD5
  - FZD7
  - FZD9
  - FZD2
  - FZD3
  - FZD1
  - FZD4
  - FZD6
  - FZD8
  - FZD10
  - CTNNB1
  - SMOC2
  - DVL3
  - DVL1
  - DVL2
  - CDH1
  - MARK2
  - APC
  - AXIN1
  - AXIN2
  - GSK3B
  - CD44
  - PTK2
  - ID1
  - SOX8
  - EP300
  - BCL9
  - OPN1LW
  - LRP6
  - LRP5
  - Sorafenib
  - Cisplatin
  - Paclitaxel
genes:
- word: Frizzled
  symbol: Frizzled
  source: bioentities_symbol
  hgnc_symbol: FZD5
  entrez: '7855'
- word: Frizzled
  symbol: Frizzled
  source: bioentities_symbol
  hgnc_symbol: FZD7
  entrez: '8324'
- word: Frizzled
  symbol: Frizzled
  source: bioentities_symbol
  hgnc_symbol: FZD9
  entrez: '8326'
- word: Frizzled
  symbol: Frizzled
  source: bioentities_symbol
  hgnc_symbol: FZD2
  entrez: '2535'
- word: Frizzled
  symbol: Frizzled
  source: bioentities_symbol
  hgnc_symbol: FZD3
  entrez: '7976'
- word: Frizzled
  symbol: Frizzled
  source: bioentities_symbol
  hgnc_symbol: FZD1
  entrez: '8321'
- word: Frizzled
  symbol: Frizzled
  source: bioentities_symbol
  hgnc_symbol: FZD4
  entrez: '8322'
- word: Frizzled
  symbol: Frizzled
  source: bioentities_symbol
  hgnc_symbol: FZD6
  entrez: '8323'
- word: Frizzled
  symbol: Frizzled
  source: bioentities_symbol
  hgnc_symbol: FZD8
  entrez: '8325'
- word: Frizzled
  symbol: Frizzled
  source: bioentities_symbol
  hgnc_symbol: FZD10
  entrez: '11211'
- word: B-catenin
  symbol: BCATENIN
  source: bioentities_symbol
  hgnc_symbol: CTNNB1
  entrez: '1499'
- word: SMOC2
  symbol: SMOC2
  source: hgnc_symbol
  hgnc_symbol: SMOC2
  entrez: '64094'
- word: Dvl
  symbol: DVL
  source: bioentities_symbol
  hgnc_symbol: DVL3
  entrez: '1857'
- word: Dvl
  symbol: DVL
  source: bioentities_symbol
  hgnc_symbol: DVL1
  entrez: '1855'
- word: Dvl
  symbol: DVL
  source: bioentities_symbol
  hgnc_symbol: DVL2
  entrez: '1856'
- word: Dvl
  symbol: DVL
  source: bioentities_symbol
  hgnc_symbol: DVL3
  entrez: '1857'
- word: Dvl
  symbol: DVL
  source: bioentities_symbol
  hgnc_symbol: DVL1
  entrez: '1855'
- word: Dvl
  symbol: DVL
  source: bioentities_symbol
  hgnc_symbol: DVL2
  entrez: '1856'
- word: CDH1
  symbol: CDH1
  source: hgnc_symbol
  hgnc_symbol: CDH1
  entrez: '999'
- word: MARK2
  symbol: MARK2
  source: hgnc_symbol
  hgnc_symbol: MARK2
  entrez: '2011'
- word: Dvl
  symbol: DVL
  source: bioentities_symbol
  hgnc_symbol: DVL3
  entrez: '1857'
- word: Dvl
  symbol: DVL
  source: bioentities_symbol
  hgnc_symbol: DVL1
  entrez: '1855'
- word: Dvl
  symbol: DVL
  source: bioentities_symbol
  hgnc_symbol: DVL2
  entrez: '1856'
- word: APC
  symbol: APC
  source: hgnc_symbol
  hgnc_symbol: APC
  entrez: '324'
- word: Axin
  symbol: AXIN
  source: bioentities_symbol
  hgnc_symbol: AXIN1
  entrez: '8312'
- word: Axin
  symbol: AXIN
  source: bioentities_symbol
  hgnc_symbol: AXIN2
  entrez: '8313'
- word: GSK3B
  symbol: GSK3B
  source: hgnc_symbol
  hgnc_symbol: GSK3B
  entrez: '2932'
- word: B-catenin
  symbol: BCATENIN
  source: bioentities_symbol
  hgnc_symbol: CTNNB1
  entrez: '1499'
- word: B-catenin
  symbol: BCATENIN
  source: bioentities_symbol
  hgnc_symbol: CTNNB1
  entrez: '1499'
- word: CD44
  symbol: CD44
  source: hgnc_symbol
  hgnc_symbol: CD44
  entrez: '960'
- word: PTK2
  symbol: PTK2
  source: hgnc_symbol
  hgnc_symbol: PTK2
  entrez: '5747'
- word: B-catenin
  symbol: BCATENIN
  source: bioentities_symbol
  hgnc_symbol: CTNNB1
  entrez: '1499'
- word: ID1
  symbol: ID1
  source: hgnc_symbol
  hgnc_symbol: ID1
  entrez: '3397'
- word: SOX8
  symbol: SOX8
  source: hgnc_symbol
  hgnc_symbol: SOX8
  entrez: '30812'
- word: p300
  symbol: p300
  source: hgnc_alias_symbol
  hgnc_symbol: EP300
  entrez: '2033'
- word: BCL9
  symbol: BCL9
  source: hgnc_symbol
  hgnc_symbol: BCL9
  entrez: '607'
- word: FZD
  symbol: FZD
  source: bioentities_symbol
  hgnc_symbol: FZD5
  entrez: '7855'
- word: FZD
  symbol: FZD
  source: bioentities_symbol
  hgnc_symbol: FZD7
  entrez: '8324'
- word: FZD
  symbol: FZD
  source: bioentities_symbol
  hgnc_symbol: FZD9
  entrez: '8326'
- word: FZD
  symbol: FZD
  source: bioentities_symbol
  hgnc_symbol: FZD2
  entrez: '2535'
- word: FZD
  symbol: FZD
  source: bioentities_symbol
  hgnc_symbol: FZD3
  entrez: '7976'
- word: FZD
  symbol: FZD
  source: bioentities_symbol
  hgnc_symbol: FZD1
  entrez: '8321'
- word: FZD
  symbol: FZD
  source: bioentities_symbol
  hgnc_symbol: FZD4
  entrez: '8322'
- word: FZD
  symbol: FZD
  source: bioentities_symbol
  hgnc_symbol: FZD6
  entrez: '8323'
- word: FZD
  symbol: FZD
  source: bioentities_symbol
  hgnc_symbol: FZD8
  entrez: '8325'
- word: FZD
  symbol: FZD
  source: bioentities_symbol
  hgnc_symbol: FZD10
  entrez: '11211'
- word: CBP
  symbol: CBP
  source: hgnc_prev_symbol
  hgnc_symbol: OPN1LW
  entrez: '5956'
- word: CD44
  symbol: CD44
  source: hgnc_symbol
  hgnc_symbol: CD44
  entrez: '960'
- word: CDH1
  symbol: CDH1
  source: hgnc_symbol
  hgnc_symbol: CDH1
  entrez: '999'
- word: LRP5/6
  symbol: LRP6
  source: hgnc_symbol
  hgnc_symbol: LRP6
  entrez: '4040'
- word: LRP5/6
  symbol: LRP5
  source: hgnc_symbol
  hgnc_symbol: LRP5
  entrez: '4041'
chemicals:
- word: Sorafenib
  source: MESH
  identifier: C471405
- word: Cisplatin
  source: MESH
  identifier: D002945
- word: Paclitaxel
  source: MESH
  identifier: D017239
diseases: []
figid_alias: PMC7884707__F4
redirect_from: /figures/PMC7884707__F4
figtype: Figure
---
